Author:
Pampalakis Georgios,Zingkou Eleni,Sotiropoulou Georgia
Abstract
Abstract
Vaginal cancer is rare and largely unexplored. We found here that kallikrein-related peptidase 5 (KLK5) is coordinately expressed along with other KLKs in all stratified epithelia, including vagina, pointing to potential role(s) in differentiation. Further, we propose that KLK5 could be implicated in vaginal cancer development based on the fact that Klk5−/− mice are prone to develop vaginal tumors when exposed to 7,12-dimethylbenz[a]anthracene. Nf-κb activation is markedly enhanced in Klk5−/−, leading to increased resistance to apoptosis of mutated vaginal cells. This explains the higher tumor numbers observed in Klk5−/− compared to wildtype. Thus, KLK5 may represent a putative suppressor of vaginal cancer.
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference50 articles.
1. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States;Cancer,2008
2. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer;Int. J. Cancer.,2008
3. The new kallikrein-like gene, KLK-L2;Molecular characterization, mapping, tissue expression, and hormonal regulation. J. Biol. Chem.,1999
4. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids;Biochim. Biophys. Acta,2003
5. The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway;Oncotarget,2014
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献